Soleus Capital Management, L.P. Terns Pharmaceuticals, Inc. Transaction History
Soleus Capital Management, L.P.
- $987 Million
- Q2 2024
A detailed history of Soleus Capital Management, L.P. transactions in Terns Pharmaceuticals, Inc. stock. As of the latest transaction made, Soleus Capital Management, L.P. holds 4,947,738 shares of TERN stock, worth $45.7 Million. This represents 3.41% of its overall portfolio holdings.
Number of Shares
4,947,738Holding current value
$45.7 Million% of portfolio
3.41%Shares
1 transactions
Others Institutions Holding TERN
# of Institutions
132Shares Held
63.4MCall Options Held
413KPut Options Held
106K-
Orbimed Advisors LLC San Diego, CA7.62MShares$70.3 Million1.25% of portfolio
-
Vivo Capital, LLC Palo Alto, CA6.18MShares$57.1 Million6.22% of portfolio
-
Deep Track Capital, LP Greenwich, CT6.1MShares$56.3 Million1.36% of portfolio
-
Black Rock Inc. New York, NY4.12MShares$38 Million0.0% of portfolio
-
Vr Adviser, LLC New York, NY3.41MShares$31.5 Million2.55% of portfolio
About Terns Pharmaceuticals, Inc.
- Ticker TERN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 37,613,800
- Market Cap $347M
- Description
- Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis (NASH) and obesity. The company develops TERN-101, a liver-distributed and non-bile acid farnesoid X receptor agonist, which is in Phase IIa clinical t...